122 related articles for article (PubMed ID: 26170971)
1. SGK3 (CISK) may induce tumor angiogenesis (Hypothesis).
Hou M; Lai Y; He S; He W; Shen H; Ke Z
Oncol Lett; 2015 Jul; 10(1):23-26. PubMed ID: 26170971
[TBL] [Abstract][Full Text] [Related]
2. Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma.
Liu M; Chen L; Chan TH; Wang J; Li Y; Li Y; Zeng TT; Yuan YF; Guan XY
Hepatology; 2012 Jun; 55(6):1754-65. PubMed ID: 22262416
[TBL] [Abstract][Full Text] [Related]
3. Serum- and glucocorticoid-regulated protein kinase 3 overexpression promotes tumor development and aggression in breast cancer cells.
Sun X; Liu X; Liu BO; Li S; Zhang D; Guo H
Oncol Lett; 2016 Jul; 12(1):437-444. PubMed ID: 27429652
[TBL] [Abstract][Full Text] [Related]
4. Functional role of SGK3 in PI3K/Pten driven liver tumor development.
Cao H; Xu Z; Wang J; Cigliano A; Pilo MG; Ribback S; Zhang S; Qiao Y; Che L; Pascale RM; Calvisi DF; Chen X
BMC Cancer; 2019 Apr; 19(1):343. PubMed ID: 30975125
[TBL] [Abstract][Full Text] [Related]
5. AKT-independent PI3-K signaling in cancer - emerging role for SGK3.
Bruhn MA; Pearson RB; Hannan RD; Sheppard KE
Cancer Manag Res; 2013; 5():281-92. PubMed ID: 24009430
[TBL] [Abstract][Full Text] [Related]
6. SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer.
Gasser JA; Inuzuka H; Lau AW; Wei W; Beroukhim R; Toker A
Mol Cell; 2014 Nov; 56(4):595-607. PubMed ID: 25458846
[TBL] [Abstract][Full Text] [Related]
7. Loss of serum and glucocorticoid-regulated kinase 3 (SGK3) does not affect proliferation and survival of multiple myeloma cell lines.
Hausmann S; Brandt E; Köchel C; Einsele H; Bargou RC; Seggewiss-Bernhardt R; Stühmer T
PLoS One; 2015; 10(4):e0122689. PubMed ID: 25837824
[TBL] [Abstract][Full Text] [Related]
8. Serum and glucocorticoid inducible protein kinases (SGKs): a potential target for cancer intervention.
Basnet R; Gong GQ; Li C; Wang MW
Acta Pharm Sin B; 2018 Sep; 8(5):767-771. PubMed ID: 30245963
[TBL] [Abstract][Full Text] [Related]
9. MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/β-catenin signaling pathways.
Kong X; Liu F; Gao J
Oncotarget; 2016 Oct; 7(40):66051-66060. PubMed ID: 27602769
[TBL] [Abstract][Full Text] [Related]
10. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
11. In vitro reconstitution of Sgk3 activation by phosphatidylinositol 3-phosphate.
Pokorny D; Truebestein L; Fleming KD; Burke JE; Leonard TA
J Biol Chem; 2021 Aug; 297(2):100919. PubMed ID: 34181950
[TBL] [Abstract][Full Text] [Related]
12. Ribonuclease inhibitor up-regulation inhibits the growth and induces apoptosis in murine melanoma cells through repression of angiogenin and ILK/PI3K/AKT signaling pathway.
Li L; Pan XY; Shu J; Jiang R; Zhou YJ; Chen JX
Biochimie; 2014 Aug; 103():89-100. PubMed ID: 24769129
[TBL] [Abstract][Full Text] [Related]
13. INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
Jin H; Yang L; Wang L; Yang Z; Zhan Q; Tao Y; Zou Q; Tang Y; Xian J; Zhang S; Jing Y; Zhang L
J Exp Clin Cancer Res; 2018 Jan; 37(1):8. PubMed ID: 29343273
[TBL] [Abstract][Full Text] [Related]
14. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
[TBL] [Abstract][Full Text] [Related]
15. Brain-derived Neurotrophic Factor Promotes Growth of Neurons and Neural Stem Cells Possibly by Triggering the Phosphoinositide 3-Kinase/ AKT/Glycogen Synthase Kinase-3β/β-catenin Pathway.
Li XT; Liang Z; Wang TT; Yang JW; Ma W; Deng SK; Wang XB; Dai YF; Guo JH; Li LY
CNS Neurol Disord Drug Targets; 2017; 16(7):828-836. PubMed ID: 28524001
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-144-3p suppresses tumor growth and angiogenesis by targeting SGK3 in hepatocellular carcinoma.
Wu M; Huang C; Huang X; Liang R; Feng Y; Luo X
Oncol Rep; 2017 Oct; 38(4):2173-2181. PubMed ID: 28849156
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cytokine-independent survival kinase (CISK) by the Phox homology domain and phosphoinositides.
Xu J; Liu D; Gill G; Songyang Z
J Cell Biol; 2001 Aug; 154(4):699-705. PubMed ID: 11514587
[TBL] [Abstract][Full Text] [Related]
18. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
20. PEST-containing nuclear protein mediates the proliferation, migration, and invasion of human neuroblastoma cells through MAPK and PI3K/AKT/mTOR signaling pathways.
Wu DD; Gao YR; Li T; Wang DY; Lu D; Liu SY; Hong Y; Ning HB; Liu JP; Shang J; Shi JF; Wei JS; Ji XY
BMC Cancer; 2018 May; 18(1):499. PubMed ID: 29716528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
